Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05178589 · ClinicalTrials.gov registry record · NA
The Role of Transcutaneous Electrical Nerve Stimulation (TENS) for Menstrual Pain Relief
A NA study of Primary Dysmenorrhea, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT05178589: Completed NA study of Primary Dysmenorrhea, sponsored by University of Southern California.
NCT05178589 is a NA study of Primary Dysmenorrhea that has completed, run by University of Southern California. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05178589, a NA study of Primary Dysmenorrhea, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The present study aims to verify the analgesic potential of a transcutaneous electrical nerve stimulation (TENS) device using patients with primary dysmenorrhea and compare it with a control period without usage.
Primary Outcome
To determine whether TENS will reduce pain symptoms in those with primary dysmenorrhea. Subjective pain will be assessed using an 11 point visual analog scale (VAS). The scale ranges from 0 to 10, with 0 being no pain and 10 being maximum pain.
Conditions Studied
Interventions
- DEVICE One Unit TENS
- DEVICE Two Unit TENS
Study Locations (1)
California
- University of Southern California Health Sciences Campus Center for Health Professions - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2023-05-01 |
| Phase | NA |
What the finished NCT05178589 record still lists
NCT05178589 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Primary Dysmenorrhea appearing as the primary indexed condition, and to 2 interventions - of which One Unit TENS is the first listed.
NCT05178589 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05178589 about?
NCT05178589 is a clinical study titled "The Role of Transcutaneous Electrical Nerve Stimulation (TENS) for Menstrual Pain Relief". The present study aims to verify the analgesic potential of a transcutaneous electrical nerve stimulation (TENS) device using patients with primary dysmenorrhea and compare it with a control period without usage.
What is the current status of trial NCT05178589?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2022-03-01. Estimated completion is 2023-05-01.
What conditions does trial NCT05178589 study?
This clinical trial studies the following conditions: Primary Dysmenorrhea.
What interventions are being tested in trial NCT05178589?
The interventions under investigation include: One Unit TENS (DEVICE), Two Unit TENS (DEVICE).
Who is sponsoring clinical trial NCT05178589?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05178589 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Dysmenorrhea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05178589's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI